Autopsy report · NCT00225355
Rosiglitazone Versus Placebo in Chronic Stable Angina
Cause of deathNo reason given
Life of this trial
- Registered 5 months before it started.
- Ran for about 9 months before it stopped.
- 80 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University of Glasgow
- Sponsor type
- University, hospital or other
- Conditions
- Angina Pectoris; Metabolic Syndrome X
- Interventions
- Rosiglitazone
- Participants
- 80 (planned, not actual)
- Sites
- 1
- Countries
- United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.